PCM
STJ

Prelude Capital Management’s St Jude Medical STJ Stock Holding History

Prelude Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-160,901
Closed -$12.9M – 1992
2016
Q4 		$12.9M Buy
160,901
+51,186
+47% +$4.06M 1.56% 4
2016
Q3 		$8.75M Sell
109,715
-8,226
-7% -$664K 0.92% 6
2016
Q2 		$9.2M Buy
+117,941
New +$8.41M 1.29% 6
2016
Q1 		– Sell
-795
Closed -$49K – 1736
2015
Q4 		$49K Buy
+795
New +$50.1K 0.01% 1055
2014
Q1 		– Sell
-4,700
Closed -$291K – 2260
2013
Q4 		$291K Buy
+4,700
New +$272K 0.05% 512

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Prelude Capital Management's STJ Position: Q1 2017 in Review

Prelude Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 160,901 shares — an estimated $12.9M sold.

Prelude Capital Management first reported a position in STJ in Q4 2013 and held it in 5 quarters. The position peaked at $12.9M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Prelude Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Prelude Capital Management sold 160,901 St Jude Medical shares in Q1 2017, an estimated $12.9M.
  • Prelude Capital Management first reported a position in St Jude Medical in Q4 2013 and held it in 5 quarters.
  • Prelude Capital Management's St Jude Medical position peaked at $12.9M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Prelude Capital Management's 13F filing for Q1 2017, filed 15 May 2017.